Société Takeda Pharmaceutical Company Limited

Société Takeda Pharmaceutical Company Limited

4502

JP3463000004

Produits pharmaceutiques

Consensus des Analystes

Actions

4502

JP3463000004

Produits pharmaceutiques

Consensus des Analystes

Métier

Ventes par activité

Ventes par région

Dirigeants

Administrateurs

Classe d'actions

Actionnaires

Participations

Coordonnées société

Sociétés du groupe

Secteur

Ventes par activité

Ventes par région

Notations pour Takeda Pharmaceutical Company Limited

Révisions de BNA

Bénéfices trimestriels - Taux de surprise

Secteur Pharmacies - Autres

Métier

Ventes par activité

Ventes par région

Dirigeants

Administrateurs

Classe d'actions

Actionnaires

Participations

Coordonnées société

Sociétés du groupe

Secteur

Ventes par activité

Ventes par région

Notations pour Takeda Pharmaceutical Company Limited

Révisions de BNA

Bénéfices trimestriels - Taux de surprise

Secteur Pharmacies - Autres

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 18/04/2024			Varia. 5j.	Varia. 1 janv.
4 089 ^JPY	+0,79 %		-1,52 %	+0,86 %

01/04	Alinamin Pharmaceutical Co. a acquis Nihon Pharmaceutical Co. auprès de Takeda Pharmaceutical Company Limited (TSE:4502).	CI
26/03	Takeda Pharmaceutical annonce que l'Adzynma est approuvé au Japon pour le traitement des troubles de la coagulation sanguine	MT

Takeda Pharmaceutical Company Limited est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques destinés essentiellement au traitement des maladies métaboliques et cardiovasculaires, des cancers et des troubles du système nerveux central. L'activité s'organise autour de 2 pôles :

- vente de médicaments et de produits de soins grand public ;

- prestations de services.

La répartition géographique du CA est la suivante : Japon (17,5%), Asie (5%), Etats-Unis (49%), Europe et Canada (20,8%), Amérique latine (3,8%), Russie et CEI (1,8%) et autres (2,1%).

Nombre d'employés: 49 095

JPY en Millions	2022	Poids	2023	Poids	Delta
Gastrointestinal 27,2 %	875 685	24,5 %	1 094 541	27,2 %	+24,99 %
Plasma Derivatives (Immune) 16,8 %	506 951	14,2 %	678 443	16,8 %	+33,83 %
Neuroscience 15,8 %	482 294	13,5 %	637 711	15,8 %	+32,22 %
Other 11,3 %	624 150	17,5 %	454 598	11,3 %	-27,17 %
Oncology 10,9 %	468 730	13,1 %	438 742	10,9 %	-6,40 %
Rare Genetic Disease and Others 10,4 %	-	-	418 724	10,4 %	-
Rare Hematology 7,6 %	283 689	7,9 %	304 718	7,6 %	+7,41 %

JPY en Millions	2022	Poids	2023	Poids	Delta
United States 52,2 %	1 714 421	48,0 %	2 103 772	52,2 %	+22,71 %
Europe and Canada 20,9 %	739 168	20,7 %	842 668	20,9 %	+14,00 %
Japan 12,7 %	658 983	18,5 %	512 043	12,7 %	-22,30 %
Asia 5,6 %	196 964	5,5 %	225 007	5,6 %	+14,24 %
Latin America 4,0 %	128 467	3,6 %	160 375	4,0 %	+24,84 %
Other 2,4 %	68 945	1,9 %	95 182	2,4 %	+38,05 %
Russia / Commonwealth of Independent States 2,2 %	62 057	1,7 %	88 431	2,2 %	+42,50 %

Dirigeants	Titre	Age	Depuis
Christophe Weber CEO	Chief Executive Officer	57	01/04/14
Gabriele Ricci CTO	Chief Tech/Sci/R&D Officer	45	01/02/22
Mwana Lugogo CMP	Compliance Officer	54	01/01/12
Michael Mendelsohn CTO	Chief Tech/Sci/R&D Officer	69	01/04/15
Andrew Plump CTO	Chief Tech/Sci/R&D Officer	58	01/02/15
Norimasa Takeda CMP	Compliance Officer	-	-
Constantine Saroukos BRD	Director/Board Member	53	01/01/15
Haruhiko Hirate IRO	Public Communications Contact	-	-
Takashi Okubo IRO	Public Communications Contact	-	-
Christopher O'Reilly IRC	Investor Relations Contact	-	01/06/11

Administrateurs	Titre	Age	Depuis
Yoshiaki Fujimori BRD	Director/Board Member	71	01/06/16
Ian Clark BRD	Director/Board Member	62	01/01/19
Steven Gillis BRD	Director/Board Member	71	01/01/19
John Maraganore BRD	Director/Board Member	60	01/06/22
Emiko Higashi BRD	Director/Board Member	64	01/06/16
Olivier Jean Bohuon BRD	Director/Board Member	65	08/01/19
Koji Hatsukawa BRD	Director/Board Member	72	01/06/16
Christophe Weber CEO	Chief Executive Officer	57	01/04/14
Constantine Saroukos BRD	Director/Board Member	53	01/01/15
Kimberly Reed BRD	Director/Board Member	53	01/06/22

	Vote	Nombre	Flottant	Autocontrôle	Flottant Total
Action A	0	1 582 408 825	1 568 410 064 ( 99,12 %)	13 486 498 ( 0,8523 %)	99,12 %

Nom	Actions	%	Valorisation
Nikko Asset Management Co., Ltd. 2,194 %	34 711 100	2,194 %	960 M ¥
Nippon Life Insurance Co. 1,564 %	24 752 000	1,564 %	684 M ¥
Takeda Science Foundation 1,132 %	17 912 000	1,132 %	495 M ¥
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0,4747 %	7 511 300	0,4747 %	208 M ¥
Swedbank Robur Fonder AB 0,3797 %	6 008 009	0,3797 %	166 M ¥
Takeda Pharmaceutical Employee Incentive Plan 0,2294 %	3 630 339	0,2294 %	100 M ¥
Sumitomo Mitsui Trust Asset Management Co., Ltd. 0,1936 %	3 062 999	0,1936 %	85 M ¥
IYOGIN HOLDINGS,INC. 0,1818 %	2 876 136	0,1818 %	80 M ¥
Takeda Pharmaceutical Director Incentive Plan 0,1427 %	2 258 019	0,1427 %	62 M ¥
Sjunde AP-fonden 0,1349 %	2 135 310	0,1349 %	59 M ¥

Nom	Actions	%	Valorisation
Nikko Asset Management Co., Ltd. 2,762 %	87 400 834	2,762 %	1 214 M ¥
Capital Research & Management Co. (Global Investors) 0,4518 %	14 297 805	0,4518 %	199 M ¥
Mondrian Investment Partners Ltd. 0,2581 %	8 167 393	0,2581 %	113 M ¥
Millennium Management LLC 0,2052 %	6 492 911	0,2052 %	90 M ¥
Eaton Vance Management 0,1532 %	4 847 535	0,1532 %	67 M ¥
The Ayco Co. LP 0,1359 %	4 302 562	0,1359 %	60 M ¥
Renaissance Technologies LLC 0,1051 %	3 327 400	0,1051 %	46 M ¥
Brandes Investment Partners LP 0,0838 %	2 651 265	0,0838 %	37 M ¥
Wells Fargo Bank NA 0,0777 %	2 458 562	0,0777 %	34 M ¥
Macquarie Investment Management Business Trust 0,0773 %	2 445 942	0,0773 %	34 M ¥

Nom	Actions	%	Valorisation
BB Gestão de Recursos DTVM SA 0,000144 %	2 276	0,000144 %	31 574 ¥

Nom	Actions	%	Valorisation
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0,47%	7 511 300	0,47%	207 653 269 $
HILLEVAX, INC. 13,53%	6 724 000	13,53%	111 820 120 $
DENALI THERAPEUTICS INC. 3,03%	4 214 559	3,03%	86 482 751 $
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. 7,21%	2 204 840	7,21%	32 327 077 $
PHATHOM PHARMACEUTICALS, INC. 4,77%	2 790 480	4,77%	29 634 898 $
OVID THERAPEUTICS INC. 10,65%	7 531 996	10,65%	22 972 588 $
NOILE-IMMUNE BIOTECH INC. 18,76%	8 119 800	18,76%	10 086 334 $
WAVE LIFE SCIENCES LTD. 0,90%	1 096 892	0,90%	6 767 824 $
EQUILLIUM, INC. 5,23%	1 842 977	5,23%	4 257 277 $

Takeda Pharmaceutical Co., Ltd.

4-1-1 Dosho-machi Chuo-Ku

540-8645, Osaka

+81 3 3278 2111

http://www.takeda.co.jp

Adresse Takeda Pharmaceutical Company Limited(4502)

Nom	Catégorie et Secteur
Takeda A/S Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.	Financial Conglomerates
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.	Pharmaceuticals: Major
Takeda Pharmaceuticals International AG Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland.	Pharmaceuticals: Major
Takeda Austria GmbH Takeda Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Austria GmbH engages in research and development of pharmaceutical products. The private company is based in Linz, Austria. Kirsten Detrick has been the CEO of the Austrian company since 2016.	Miscellaneous Commercial Services
Takeda GmbH Takeda GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Konstanz, Germany. The CEOs are Wolfgang Eck, Uwe Hoffmeister, Roland Kurney. The company was founded in 1873.	Pharmaceuticals: Major
Takeda Manufacturing Austria AG Takeda Manufacturing Austria AG Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Manufacturing Austria AG manufactures and supplies vital medicines and medical devices. The private company is based in Vienna, Austria.	Pharmaceuticals: Major
Shire Ireland Finance Trading Ltd.
Shire Biotech India Pvt Ltd.
Shire Biotech UK Holdings Ltd. Shire Biotech UK Holdings Ltd. Financial ConglomeratesFinance Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding private company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company.	Financial Conglomerates
Takeda Belgium NV Takeda Belgium NV Medical DistributorsDistribution Services Founded in 1835, Takeda Belgium NV is a subsidiary of Takeda Pharmaceutical Co., Ltd. The private company is based in Zaventem, Belgium and focuses on providing better healthcare solutions for their patients. Takeda Belgium's mission is centered around the question of how they can do more for their patients.	Medical Distributors

Note Trading

Note Investissement

ESG Refinitiv

B+

Plus de notations

Vente

Achat

Recommandation moyenne

ACCUMULER

Nombre d'Analystes

Dernier Cours de Cloture

4 057 JPY

Objectif de cours Moyen

4 790 JPY

Ecart / Objectif Moyen

+18,07 %

Consensus

Révisions des Estimations

Agenda de la société

	Varia. 1 janv.	Capi.
TAKEDA PHARMACEUTICAL COMPANY LIMITED	+0,86 %	41,16 Md
ELI LILLY AND COMPANY	+28,79 %	676 Md
NOVO NORDISK A/S	+24,02 %	554 Md
JOHNSON & JOHNSON	-7,64 %	349 Md
MERCK & CO., INC.	+15,00 %	318 Md
ABBVIE INC.	+5,99 %	291 Md
ASTRAZENECA PLC	+3,19 %	210 Md
NOVARTIS AG	-0,28 %	204 Md
ROCHE HOLDING AG	-9,57 %	194 Md
PFIZER, INC.	-11,71 %	144 Md

Pharmacies - Autres

Recherche pharmaceutique et médicale

Produits pharmaceutiques

Produits pharmaceutiques

Pharmacies - Autres